B. Bogen

B. Bogen, C. Okada, K. Stockerl-Goldstein, 1997, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T helper cell recognition of idiotopes on λ2 light chains of M315 and T952: evidence for dependence on somatic mutations in the third hypervariable region

B. Bogen, K. Hannestad, T. Jørgensen, 1985 .

A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza

R. Cox, Fan Zhou, B. Bogen, 2017, Journal of Virology.

Targeting Xcr1 on Dendritic Cells Rapidly Induce Th1-Associated Immune Responses That Contribute to Protection Against Influenza Infection

Even Fossum, B. Bogen, P. Huszthy, 2022, Frontiers in Immunology.

Cutting Edge: Link Between Innate and Adaptive Immunity: Toll-Like Receptor 2 Internalizes Antigen for Presentation to CD4+ T Cells and Could Be an Efficient Vaccine Target1

T. Espevik, N. Nilsen, B. Bogen, 2003, The Journal of Immunology.

Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation

F. Baron, B. Bogen, J. Zilberberg, 2014, PloS one.

The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells.

B. Bogen, G. Lauritzsen, 1993, Cellular immunology.

Primary antitumor immune response mediated by CD4+ T cells.

Guttorm Haraldsen, Alexandre Corthay, B. Bogen, 2005, Immunity.

Tumor Killing by CD4+ T Cells Is Mediated via Induction of Inducible Nitric Oxide Synthase-Dependent Macrophage Cytotoxicity

B. Bogen, F. Skjeldal, O. Haabeth, 2018, Front. Immunol..

Tumor-specific CD4+ T cells eradicate myeloma cells genetically deficient in MHC class II display

B. Bogen, O. Haabeth, A. Tveita, 2016, Oncotarget.

Limitations of bystander killing in Th1/M1 immune responses against a secreted tumor antigen

B. Bogen, O. Haabeth, A. Tveita, 2014, Oncoimmunology.

Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.

B. Bogen, Z. Dembić, K. Schenck, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Surface Expression of Transglutaminase 2 by Dendritic Cells and its Potential Role for Uptake and Presentation of Gluten Peptides to T Cells

M. Ráki, L. Sollid, Ø. Molberg, 2007, Scandinavian journal of immunology.

ARHGAP45 controls naïve T‐ and B‐cell entry into lymph nodes and T‐cell progenitor thymus seeding

Even Fossum, B. Malissen, S. Audebert, 2021, EMBO reports.

Target T Cells and Could Be an Efficient Vaccine +Internalizes Antigen for Presentation to CD4 Adaptive Immunity: Toll-Like Receptor 2 Cutting Edge: Link Between Innate and

T. Espevik, N. Nilsen, B. Bogen, 2003 .

H‐2‐Linked Ir Genes Have a Striking Influence on the Immunogenicity of Idiotopes of Myeloma Protein 315 for T Helper Cells

B. Bogen, K. Hannestad, T. Jørgensen, 1985, Scandinavian journal of immunology.

Systemic Autoimmune Disease Caused by Autoreactive B Cells That Receive Chronic Help from Ig V Region-Specific T Cells1

B. Bogen, A. Corthay, L. Munthe, 2005, The Journal of Immunology.

Clonal deletion of specific thymocytes by an immunoglobulin idiotype.

S. Weiss, B. Bogen, Z. Dembić, 1993, The EMBO journal.

Spleen tyrosine kinase inhibitors reduce CD40L-induced proliferation of chronic lymphocytic leukemia cells but not normal B cells

K. Taskén, G. Tjønnfjord, B. Bogen, 2016, Haematologica.

Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences.

B. Bogen, A. Fredriksen, 2007, Blood.

A model for cancer-suppressive inflammation

B. Bogen, A. Corthay, O. Haabeth, 2012, Oncoimmunology.

Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer

I. Donaldson, B. Bogen, A. Corthay, 2011, Nature communications.

Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.

Hyunkeun Song, Sungyoul Hong, B. Bogen, 2013, Immunology letters.

Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells.

Keith M. Thompson, Dong Wang, G. Tjønnfjord, 2013, Cell reports.

Expanding the Versatility of Phage Display I: Efficient Display of Peptide-Tags on Protein VII of the Filamentous Phage

I. Sandlie, G. Løset, B. Bogen, 2011, PloS one.

Tumors Escape CD4+ T-cell-Mediated Immunosurveillance by Impairing the Ability of Infiltrating Macrophages to Indirectly Present Tumor Antigens.

B. Bogen, O. Haabeth, F. Schjesvold, 2015, Cancer research.

Neoantigen vaccine-induced CD4 T cells confer protective immunity in a mouse model of multiple myeloma through activation of CD8 T cells against non-vaccine, tumor-associated antigens

B. Bogen, D. Levey, J. Castle, 2022, Journal for ImmunoTherapy of Cancer.

How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

B. Bogen, P. Hofgaard, Z. Dembić, 2014, Front. Immunol..

Secretion of tumor-specific antigen by myeloma cells is required for cancer immunosurveillance by CD4+ T cells.

B. Bogen, P. Hofgaard, A. Corthay, 2009, Cancer research.

Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules

B. Bogen, W. Haas, Bernhard Malissen, 1986, European journal of immunology.

Delivery of Antigen to CD40 Induces Protective Immune Responses against Tumors1

B. Bogen, K. Schjetne, A. Fredriksen, 2007, The Journal of Immunology.

Human XCR1+ Dendritic Cells Derived In Vitro from CD34+ Progenitors Closely Resemble Blood Dendritic Cells, Including Their Adjuvant Responsiveness, Contrary to Monocyte-Derived Dendritic Cells

Even Fossum, C. Caux, Hong Liu, 2014, The Journal of Immunology.

Human XCR 1 + Dendritic Cells Derived In Vitro from CD 34 + Progenitors Closely Resemble Blood Dendritic Cells , Including Their Adjuvant Responsiveness , Contrary to Monocyte-Derived Dendritic Cells

Even Fossum, C. Caux, Hong Liu, 2014 .

Monocyte-Derived Dendritic Cells Their Adjuvant Responsiveness , Contrary to Resemble Blood Dendritic Cells , Including Progenitors Closely + Vitro from CD 34 Dendritic Cells Derived In + Human XCR

Even Fossum, Hong Liu, C. Chabannon, 2014 .

Phosphorylation-mediated EZH 2 inactivation promotes drug resistance in multiple myeloma

Y. Furukawa, J. Kikuchi, B. Bogen, 2018 .

Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma.

Y. Furukawa, J. Kikuchi, B. Bogen, 2015, The Journal of clinical investigation.

Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells

I. Sandlie, B. Bogen, A. Fredriksen, 2012, Front. Oncol..

Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera

Ø. Førre, J. Natvig, B. Bogen, 1995, Clinical and experimental immunology.

The Inhibitor of Death Receptor Signaling, Flice-Inhibitory Protein Defines a New Class of Tumor Progression Factors

P. Biberfeld, M. Djerbi, A. Grandien, 1999, The Journal of experimental medicine.

Lymphomas can develop from B cells chronically helped by idiotype-specific T cells

J. Kutok, L. Meza-Zepeda, B. Bogen, 2007, The Journal of experimental medicine.

Idiotypes and T Cell Selection

S. Weiss, B. Bogen, Z. Dembić, 2020 .

Deletion of idiotype (Id)-specific T cells in multiple myeloma.

B. Bogen, Z. Dembić, K. Schenck, 2000, Acta oncologica.

Resting small B cells present endogenous immunoglobulin variable‐region determinants to idiotope‐specific CD4+ T cells in vivo

B. Bogen, J. Kyte, L. Munthe, 1999, European journal of immunology.

Processing and presentation of idiotypes to MHC-restricted T cells.

S. Weiss, B. Bogen, 1993, International reviews of immunology.

Functional phage display of two murine α/β T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance

I. Sandlie, G. Løset, B. Bogen, 2007 .

Liver Metastasis of Cancer Facilitated by Chemokine Receptor CCR6

J. Dellacasagrande, B. Bogen, P. Hofgaard, 2003, Scandinavian journal of immunology.

Anti‐Tumour Activity of Idiotype‐Specific, MHC‐Restricted Th1 and Th2 Clones In Vitro and In Vivo

S. Weiss, B. Bogen, G. Lauritzsen, 1993, Scandinavian journal of immunology.

T helper cells recognize an idiotope located on peptide 88-114/117 of the light chain variable domain of an isologous myeloma protein (315)

B. Bogen, K. Hannestad, T. Jørgensen, 1983, The Journal of experimental medicine.

Specificity of antibody and helper T-cell responses to the isologous myeloma protein W3129 and its subunits.

B. Bogen, K. Hannestad, 1984, Molecular immunology.

Expression of SH2D2A in T-cells is regulated both at the transcriptional and translational level.

H. Aasheim, A. Spurkland, F. Johansen, 2008, Molecular immunology.

'Troy-bodies': antibodies as vector proteins for T cell epitopes.

I. Sandlie, B. Bogen, T. Gregers, 2001, Biomolecular engineering.

“Troy-bodies”: Recombinant Antibodies that Target T Cell Epitopes to Antigen Presenting Cells

I. Sandlie, B. Bogen, J. K. Eidem, 2001, International reviews of immunology.

Polarizing T and B Cell Responses by APC-Targeted Subunit Vaccines

Even Fossum, B. Bogen, G. Grødeland, 2015, Front. Immunol..

Thymic skewing of the CD4/CD8 ratio maps with the T-cell receptor alpha-chain locus.

R. Schwartz, D. Lo, N. Gascoigne, 1998, Current biology : CB.

Unlocking bat immunology: establishment of Pteropus alecto bone marrow-derived dendritic cells and macrophages

F. Ginhoux, Even Fossum, P. Zhou, 2016, Scientific Reports.

The heat shock transcription factor 1 as a potential new therapeutic target in multiple myeloma

H. Einsele, M. Andrulis, A. Beilhack, 2013, British journal of haematology.

Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery.

Even Fossum, M. Bajénoff, B. Malissen, 2016, Immunity.

Targeting of nucleoprotein to chemokine receptors by DNA vaccination results in increased CD8(+)-mediated cross protection against influenza.

B. Bogen, M. Baranowska, C. Hoornaert, 2015, Vaccine.

Coupling of HIV-1 Antigen to the Selective Autophagy Receptor SQSTM1/p62 Promotes T-Cell-Mediated Immunity

A. Simonsen, B. Bogen, I. Øynebråten, 2016, Front. Immunol..

Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides—As Antigens for Th Cells

B. Bogen, K. Thompson, L. Munthe, 2015, Front. Immunol..

Naive Idiotope-Specific B and T Cells Collaborate Efficiently in the Absence of Dendritic Cells

B. Bogen, O. Haabeth, A. Tveita, 2014, The Journal of Immunology.

B‐cell tolerance to the B‐cell receptor variable regions

J. Andersen, O. Bakke, G. Abrahamsen, 2013, European journal of immunology.

Review: To What Extent are T Cells Tolerant to Immunoglobulin Variable Regions?

B. Bogen, P. Ruffini, 2009, Scandinavian journal of immunology.

Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.

B. Bogen, A. Corthay, K. Thompson, 2006, Haematologica.

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models

B. Bogen, T. Gedde-Dahl, Z. Dembić, 2004, Cancer Immunology, Immunotherapy.

Restricted α/β receptor gene usage of idiotype‐specific major histocompatibility complex‐restricted T cells: Selection for CDR3‐related sequences

H. Snodgrass, B. Bogen, E. Bruyns, 1992 .

Targeting of HA to chemokine receptors induces strong and cross-reactive T cell responses after DNA vaccination in pigs.

Even Fossum, B. Bogen, G. Grødeland, 2019, Vaccine.

The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin

Even Fossum, P. Hervé, C. Chevalier, 2017, Scientific Reports.

Antigen Targeting to Human HLA Class II Molecules Increases Efficacy of DNA Vaccination

L. Fugger, G. Løset, B. Bogen, 2016, The Journal of Immunology.

Recombinant antibodies as carrier proteins for sub-unit vaccines: influence of mode of fusion on protein production and T-cell activation.

A. Rees, I. Sandlie, B. Bogen, 2000, Journal of immunological methods.

Cutting Edge: Expression of XCR1 Defines Mouse Lymphoid-Tissue Resident and Migratory Dendritic Cells of the CD8α+ Type

Even Fossum, B. Malissen, M. Guilliams, 2011, The Journal of Immunology.

Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches

C. Berek, V. T. Chu, R. Manz, 2014, PloS one.

Targeting Conventional Dendritic Cells to Fine-Tune Antibody Responses

Even Fossum, B. Bogen, A. Gudjonsson, 2019, Front. Immunol..

Dendritic cell targeted Ccl3- and Xcl1-fusion DNA vaccines differ in induced immune responses and optimal delivery site

Even Fossum, B. Bogen, A. Gudjonsson, 2019, Scientific Reports.

Prevention of Bone Destruction by Mechanical Loading Is Not Enhanced by the Bruton’s Tyrosine Kinase Inhibitor CC-292 in Myeloma Bone Disease

G. Duda, B. Bogen, B. Willie, 2021, International journal of molecular sciences.

Weak positive selection of transgenic T cell receptor‐bearing thymocytes: importance of major histocompatibility complex class II, T cell receptor and CD4 surface molecule densities

B. Bogen, Z. Dembić, Siegfried Weiss, 1992, European journal of immunology.

Mechanical loading prevents bone destruction and exerts anti-tumor effects in the MOPC315.BM.Luc model of myeloma bone disease.

G. Duda, A. Beilhack, M. Lynch, 2020, Acta biomaterialia.

Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model

Weontae Lee, Heeyoun Kim, B. Bogen, 2017, Yonsei medical journal.

Synthetic peptides and β‐chain gene rearrangements reveal a diversified T cell repertoire for a λ light chain third hypervariable region

J. Briand, B. Bogen, R. Snodgrass, 1986 .

Molecular profiling of tumor-specific TH1 cells activated in vivo

T. Clancy, B. Bogen, A. Corthay, 2013, Oncoimmunology.

No recombinations between Tcra-V and Tcra-C gene segments in 669 backcross mice

B. Bogen, R. Snodgrass, L. Gleditsch, 2004, Immunogenetics.

Is Secretion of Tumour‐specific Antigen Important for Cancer Eradication by CD4+ T Cells? – Implications for Cancer Immunotherapy by Adoptive T Cell Transfer

B. Bogen, A. Corthay, K. B. Lorvik, 2011, Scandinavian journal of immunology.

Preferential Positive Selection of T Lymphocytes which Express Two Different TCRα Chains, an Endogenous and a Transgenic

B. Bogen, Z. Dembić, L. Munthe, 1995, Scandinavian journal of immunology.

Processing of an Antigenic Sequence from IgG Constant Domains for Presentation by MHC Class II1

I. Sandlie, T. Michaelsen, B. Bogen, 2008, The Journal of Immunology.

Class II IgG Constant Domains for Presentation by Processing of an Antigenic Sequence from and

I. Sandlie, T. Michaelsen, B. Bogen, 2008 .

Dual T cell receptor T cells have a decreased sensitivity to physiological ligands due to reduced density of each T cell receptor

J. S. Røtnes, B. Bogen, L. Munthe, 1996, European journal of immunology.

Ca2+ mobilization in physiologically stimulated single T cells gradually increases with peptide concentration (analog signaling)

J. S. Røtnes, B. Bogen, 1994, European journal of immunology.

DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.

I. Sandlie, B. Bogen, A. Fredriksen, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region.

J. Briand, B. Bogen, R. Snodgrass, 1986, European journal of immunology.

Recombinant antibodies for delivery of antigen: a single loop between beta-strands in the constant region can accommodate long, complex and tandem T cell epitopes.

L. Sollid, I. Sandlie, G. Tunheim, 2008, International immunology.

Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA

Kristin S. Gunnarsen, I. Sandlie, G. Løset, 2010, BMC biotechnology.

Systemic therapy with oncolytic myxoma virus cures established residual multiple myeloma in mice

E. Bartee, B. Bogen, Xue-Zhong Yu, 2016, Molecular therapy oncolytics.

Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model

S. Naderi, R. Blomhoff, A. Sundan, 2011, BMC Cancer.

Restricted alpha/beta receptor gene usage of idiotype-specific major histocompatibility complex-restricted T cells: selection for CDR3-related sequences.

H. Snodgrass, B. Bogen, E. Bruyns, 1992, European journal of immunology.

A Public T cell Receptor Recognized by a Monoclonal Antibody Specific for the D‐J Junction of the β‐chain

I. Sandlie, G. Løset, B. Bogen, 2013, Scandinavian journal of immunology.

Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display

S. Justesen, S. Buus, Kristin S. Gunnarsen, 2013, Scientific Reports.

Human chemokine MIP1α increases efficiency of targeted DNA fusion vaccines.

B. Bogen, P. Ruffini, G. Grødeland, 2010, Vaccine.

Targeted idiotype‐fusion DNA vaccines for human multiple myeloma: preclinical testing

B. Bogen, T. Gedde-Dahl, K. Thompson, 2011, European journal of haematology.

Neoantigen Synthetic Peptide Vaccine for Multiple Myeloma Elicits T Cell Immunity in a Pre-Clinical Model

J. Castle, Mohamed Uduman, M. Findeis, 2017 .

EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress

Y. Furukawa, N. Takahashi, J. Kikuchi, 2022, Blood advances.

PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

E. Shin, Jin Seok Kim, Hoyoung Lee, 2020, Clinical Cancer Research.

SH2D2A Modulates T Cell Mediated Protection to a B Cell Derived Tumor in Transgenic Mice

G. Abrahamsen, A. Spurkland, B. Bogen, 2012, PloS one.

Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model

B. Dörken, G. Duda, A. Leutz, 2014, Blood Cancer Journal.

Polarity of CD4+ T cells towards the antigen presenting cell is regulated by the Lck adapter TSAd

G. Abrahamsen, M. Habtamu, A. Spurkland, 2018, Scientific Reports.

A DNA Vaccine That Encodes an Antigen-Presenting Cell-Specific Heterodimeric Protein Protects against Cancer and Influenza

Even Fossum, B. Bogen, J. Blaževski, 2020, Molecular therapy. Methods & clinical development.

Monoclonal antibodies produced by muscle after plasmid injection and electroporation.

I. Sandlie, T. Tjelle, T. Michaelsen, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Needle-free delivery of DNA: Targeting of hemagglutinin to MHC class II molecules protects rhesus macaques against H1N1 influenza.

B. Bogen, D. Mortier, G. Koopman, 2019, Vaccine.

The Matrigel Cytokine Assay

B. Bogen, A. Corthay, O. Haabeth, 2011 .

MHC-Restricted Ig V Region-Driven T-B Lymphocyte Collaboration: B Cell Receptor Ligation Facilitates Switch to IgG Production

B. Bogen, L. Munthe, M. Zangani, 2004, The Journal of Immunology.

Enhanced germinal center reaction by targeting vaccine antigen to major histocompatibility complex class II molecules

B. Bogen, R. Gopalakrishnan, A. Tveita, 2019, npj Vaccines.

Trimeric, APC-Targeted Subunit Vaccines Protect Mice against Seasonal and Pandemic Influenza

B. Bogen, Tor Kristian Andersen, G. Grødeland, 2023, Journal of virology.

Antibody-mediated delivery of T-cell epitopes to antigen-presenting cells induce strong CD4 and CD8 T-cell responses.

J. Andersen, I. Sandlie, T. Michaelsen, 2021, Vaccine.

The idiotype connection: linking infection and multiple sclerosis.

T. Holmøy, F. Vartdal, B. Bogen, 2010, Trends in immunology.

T cells with two Tcrbeta chains and reactivity to both MHC/idiotypic peptide and superantigen.

B. Bogen, Z. Dembić, L. Munthe, 1996, Cellular immunology.

Pandemic Preparedness Against Influenza: DNA Vaccine for Rapid Relief

S. Mjaaland, F. Oftung, J. Bodin, 2021, Frontiers in Immunology.

Antibody Responses to λ1J558 and λ2315 Light Chains

B. Bogen, 1984 .

Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance.

I. Sandlie, G. Løset, B. Bogen, 2007, Protein engineering, design & selection : PEDS.

Preclinical Evaluation of a 64Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma

R. Tripier, B. Bogen, F. Haddad, 2023, Pharmaceutics.

Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis

L. Kwak, A. Biragyn, B. Bogen, 2004, Journal of leukocyte biology.

An Early Myeloma Bone Disease Model in Skeletally Mature Mice as a Platform for Biomaterial Characterization of the Extracellular Matrix

A. Rack, P. Zaslansky, B. Bogen, 2020, Journal of oncology.

Heterodimeric Barnase-Barstar Vaccine Molecules: Influence of One versus Two Targeting Units Specific for Antigen Presenting Cells

B. Bogen, Ranveig Braathen, H. C. L. Spång, 2012, PloS one.

Clonal deletion ofspecific thymocytes byan immunoglobulin idiotype

S. Weiss, B. Bogen, Z. Dembić, 1993 .

T‐Cell Receptor Alpha Haplotype influences Vα Epitope Expression on both Cortisone‐Resistant Thymocytes and Lymph Node T Cells

B. Bogen, L. Gleditsch, A. Teig, 1993, Scandinavian journal of immunology.

Induction of Cross-Reactive and Protective Antibody Responses After DNA Vaccination With MHCII-Targeted Stem Domain From Influenza Hemagglutinin

D. Nemazee, J. Teijaro, B. Bogen, 2020, Frontiers in Immunology.

3-O sulfation of syndecan-1 mediated by the sulfotransferase HS3ST3a1 enhances myeloma aggressiveness.

J. Moreaux, B. Bogen, A. Zeller, 2023, Matrix biology : journal of the International Society for Matrix Biology.

Review: To What Extent are T Cells Tolerant to Immunoglobulin Variable Regions?

B. Bogen, P. Ruffini, 2009, Scandinavian Journal of Immunology.

Is Secretion of Tumour‐specific Antigen Important for Cancer Eradication by CD4+ T Cells? – Implications for Cancer Immunotherapy by Adoptive T Cell Transfer

B. Bogen, A. Corthay, K. B. Lorvik, 2011, Scandinavian journal of immunology.

Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza.

Even Fossum, B. Bogen, Ranveig Braathen, 2023, Molecular Therapy.

Broad and Largely Concordant Molecular Changes Characterize Tolerogenic and Immunogenic Dendritic Cell Maturation in Thymus and Periphery.

Even Fossum, B. Malissen, Samira Tamoutounour, 2016, Immunity.

Id-neoantigen vaccine induces therapeutic CD8+ T cells against multiple myeloma: H chain-loss escapees cause FLC MM

Even Fossum, B. Bogen, P. Hofgaard, 2023, Journal for ImmunoTherapy of Cancer.

103 Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein

B. Bogen, K. Thompson, E. Egaas, 2012, The World Allergy Organization Journal.

Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1+ Dendritic Cells Induces Potent Antitumoral Responses

Even Fossum, B. Malissen, D. Terhorst, 2015, The Journal of Immunology.

InfluenzaAntibody-Mediated Protection against MHC Class II Molecules Rapidly Induces DNA Vaccine that Targets Hemagglutinin to

K. Roux, S. Mjaaland, B. Bogen, 2013 .